Sections were washed three times with TBST and counterstained with DAPI (5 mg/mL, 1:10,000, Invitrogen) for 5 min to label nuclei
Use this page for dose steps, timing, vial mixing, and storage
F.HsiungY
Phase 2 weight loss (48 weeks): 8.7% at 2 mg maintenance 4 mg Weeks 58 First dose where therapeutic effects become clinically meaningful
To avoid such mispairings and eliminate emulsion transfers, some studies have leveraged less efficient single emulsion workflows 16
IGF1 LR3 is preferable when research mainly focuses on IGF-1 receptor signaling, when sustained receptor start is desired, when practical factors favor less frequent use, when glucose-lowering rather than glucose-raising effects are acceptable, or when cost-effectiveness is important